(Q44840997)

6 December 2017

title

Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy (English)

1 reference

oral squamous cell carcinoma

6 December 2017

0 references

1 reference

Oliver Driemel

1

1 reference

6 December 2017

Tobias Ettl

2

1 reference

6 December 2017

Oliver Kölbl

3

1 reference

6 December 2017

Torsten E Reichert

4

1 reference

6 December 2017

Bernd V Dresp

5

1 reference

6 December 2017

Jürgen Reuther

6

1 reference

6 December 2017

Hans Pistner

7

1 reference

6 December 2017

language of work or name

1 reference

15 May 2009

1 reference

Strahlentherapie und Onkologie

6 December 2017

published in

1 reference

6 December 2017

volume

185

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

296-302

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-009-1914-y

6 December 2017

exact match

0 references

cites work

Preoperative chemoradiotherapy in the management of oral cancer: a review

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-009-1914-Y

Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-009-1914-Y

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 January 2018

1 reference

12 December 2020

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

1 reference

12 December 2020

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)

1 reference

12 December 2020

Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity

1 reference

12 December 2020

Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome

1 reference

12 December 2020

Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity.

1 reference

12 December 2020

[Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors]

1 reference

12 December 2020

Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer

1 reference

12 December 2020

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab

1 reference

12 December 2020

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up)

1 reference

12 December 2020

p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study

1 reference

12 December 2020

Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor

1 reference

12 December 2020

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

12 December 2020

The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer

1 reference

12 December 2020

Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients.

1 reference

12 December 2020

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

1 reference

12 December 2020

Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

1 reference

12 December 2020

Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors

1 reference

12 December 2020

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

12 December 2020

Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer

1 reference

12 December 2020

Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results

1 reference

12 December 2020

Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts

1 reference

12 December 2020

Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.

1 reference

12 December 2020

[Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study]

1 reference

12 December 2020

Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy

1 reference

12 December 2020

[Preoperative radiochemotherapy for advanced oral cavity tumours : the Kiel DOSAK experience regarding curability and quality of life]

1 reference

12 December 2020

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

12 December 2020

Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival

1 reference

12 December 2020

Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors

1 reference

12 December 2020

Predictive factors for the histologic response to preoperative radiotherapy in advanced oral cancer

1 reference

12 December 2020

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

12 December 2020

The expanding role of systemic therapy in head and neck cancer

1 reference

12 December 2020

Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients

1 reference

12 December 2020

Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma

1 reference

12 December 2020

Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study

1 reference

12 December 2020

[Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors]

1 reference

12 December 2020

[Oral squamous cell carcinoma Retrospective analysis of therapy results and prognosis by neoadjuvant, preoperative radio-chemotherapy]

1 reference

12 December 2020

Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study

1 reference

12 December 2020

10.1007/S00066-009-1914-Y

Identifiers

DOI

1 reference

6 December 2017

1 reference